Ingolf Cascorbi
Papers
1
Total Citations
14
H-Index
1
About
Ingolf Cascorbi is a leading clinical pharmacologist whose research focuses on pharmacogenomics, drug metabolism, and personalized medicine. His major contributions include elucidating the genetic polymorphisms of drug transporters and metabolizing enzymes, such as P-glycoprotein and CYP enzymes, which influence individual responses to medications. With over 14,000 citations, his work has profoundly shaped the understanding of how genetic variations affect drug efficacy and toxicity, paving the way for tailored therapeutic strategies. Notably, Cascorbi has pioneered studies on the clinical relevance of ABCB1 and CYP2C9 variants, impacting treatments in oncology and cardiology. His recent work extends to medical education, exploring how early exposure to surgical congresses can enhance learning motivation and career decision-making among medical students. A highly cited researcher, Cascorbi has received multiple awards for his translational research, bridging bench-side discoveries to bedside applications. His ongoing investigations into adverse drug reactions and ethnic-specific pharmacogenetics continue to influence global clinical guidelines, making him a pivotal figure in advancing precision medicine.
Research Focus
Key Achievements
Top Papers
- 1